Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3159)
MapLight Therapeutics, Inc. (MPLT)
Catalyst4, Inc. — 10% Owner
Shares
4,400,000
Price
$11.38
Total Value
$50.07M
Shares Held After
25,306,689
% of Holdings
17.4%
Adagene Inc. (ADAG)
DO CUONG V — Director
Shares
2,000
Price
$3.75
Total Value
$7.50K
Shares Held After
2,000
% of Holdings
100.0%
Verrica Pharmaceuticals Inc. (VRCA)
Rieger Jayson — Director
Shares
20,000
Price
$5.06
Total Value
$101.20K
Shares Held After
202,593
% of Holdings
9.9%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$19.74
Total Value
$349.73K
Shares Held After
140,568
% of Holdings
11.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
33,787
Price
$3.85
Total Value
$130.00K
Shares Held After
581,059
% of Holdings
5.8%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
2,279
Price
$112.64
Total Value
$256.71K
Shares Held After
1,074,543
% of Holdings
0.2%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
4,668
Price
$111.44
Total Value
$520.21K
Shares Held After
1,076,822
% of Holdings
0.4%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
3,053
Price
$110.49
Total Value
$337.34K
Shares Held After
1,081,490
% of Holdings
0.3%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$74.54
Total Value
$74.54K
Shares Held After
0
% of Holdings
100.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
3,664
Price
$114.49
Total Value
$419.49K
Shares Held After
9,755
% of Holdings
27.3%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,292
Price
$34.77
Total Value
$79.69K
Shares Held After
130,625
% of Holdings
1.7%
Sagimet Biosciences Inc. (SGMT)
Kemble George — Director
Shares
350,987
Price
$10.23
Total Value
$3.59M
Shares Held After
62,161
% of Holdings
85.0%
Apollomics Inc. (APLM)
Chen Hung-Wen — Director
Shares
266,667
Price
$15.00
Total Value
$4.00M
Shares Held After
1,029,695
% of Holdings
25.9%
Apollomics Inc. (APLM)
Chen Hung-Wen — Director
Shares
103,333
Price
$15.00
Total Value
$1.55M
Shares Held After
418,334
% of Holdings
24.7%
Apollomics Inc. (APLM)
Chen Hung-Wen — Director
Shares
166,667
Price
$12.00
Total Value
$2.00M
Shares Held After
315,001
% of Holdings
52.9%
Apollomics Inc. (APLM)
LIN PETER KUAN-HOW — Chief Financial Officer
Shares
26,667
Price
$15.00
Total Value
$400.00K
Shares Held After
48,979
% of Holdings
54.4%
Apollomics Inc. (APLM)
Chen Yi-Kuei — Director
Shares
20,000
Price
$15.00
Total Value
$300.00K
Shares Held After
121,248
% of Holdings
16.5%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
12,000
Price
$3.79
Total Value
$45.46K
Shares Held After
3,084,000
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
322,465
Price
$25.00
Total Value
$8.06M
Shares Held After
428,946
% of Holdings
42.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
478,377
Price
$25.00
Total Value
$11.96M
Shares Held After
567,358
% of Holdings
45.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,359,674
Price
$25.00
Total Value
$33.99M
Shares Held After
2,441,454
% of Holdings
35.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
321
Price
$500.93
Total Value
$160.80K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,148
Price
$500.05
Total Value
$1.07M
Shares Held After
324,764
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,630
Price
$499.30
Total Value
$1.81M
Shares Held After
326,912
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,130
Price
$498.39
Total Value
$1.06M
Shares Held After
330,542
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
537
Price
$497.22
Total Value
$267.01K
Shares Held After
332,672
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
414
Price
$495.96
Total Value
$205.33K
Shares Held After
333,209
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$495.02
Total Value
$158.41K
Shares Held After
333,623
% of Holdings
0.1%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal&Compliance
Shares
42,666
Price
$11.13
Total Value
$474.77K
Shares Held After
37,569
% of Holdings
53.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
40
Price
$333.23
Total Value
$13.33K
Shares Held After
50,000
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
3,095
Price
$331.43
Total Value
$1.03M
Shares Held After
50,040
% of Holdings
5.8%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
4,896
Price
$330.36
Total Value
$1.62M
Shares Held After
53,135
% of Holdings
8.4%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
7,428
Price
$329.60
Total Value
$2.45M
Shares Held After
58,031
% of Holdings
11.3%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
1,687
Price
$328.52
Total Value
$554.21K
Shares Held After
65,459
% of Holdings
2.5%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
5,226
Price
$327.39
Total Value
$1.71M
Shares Held After
67,146
% of Holdings
7.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
2,287
Price
$326.60
Total Value
$746.94K
Shares Held After
72,372
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
341
Price
$325.60
Total Value
$111.03K
Shares Held After
74,659
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,847
Price
$111.14
Total Value
$427.55K
Shares Held After
31,034
% of Holdings
11.0%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
9,193
Price
$110.00
Total Value
$1.01M
Shares Held After
34,881
% of Holdings
20.9%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,200
Price
$109.11
Total Value
$1.11M
Shares Held After
44,074
% of Holdings
18.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
14,696
Price
$107.97
Total Value
$1.59M
Shares Held After
54,274
% of Holdings
21.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,434
Price
$107.14
Total Value
$1.12M
Shares Held After
68,970
% of Holdings
13.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,630
Price
$106.05
Total Value
$384.96K
Shares Held After
79,404
% of Holdings
4.4%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
37,200
Price
$10.32
Total Value
$383.90K
Shares Held After
482,800
% of Holdings
7.7%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
226
Price
$26.28
Total Value
$5.94K
Shares Held After
153,982
% of Holdings
0.1%
Cue Biopharma, Inc. (CUE)
Meluzio Michael Vincent — VP, Prin. Accounting Officer
Shares
3
Price
$31.13
Total Value
$93.39
Shares Held After
48,961
% of Holdings
0.0%
Cue Biopharma, Inc. (CUE)
Meluzio Michael Vincent — VP, Prin. Accounting Officer
Shares
4,106
Price
$30.35
Total Value
$124.62K
Shares Held After
48,964
% of Holdings
7.7%
Cue Biopharma, Inc. (CUE)
Meluzio Michael Vincent — VP, Prin. Accounting Officer
Shares
1,519
Price
$29.37
Total Value
$44.61K
Shares Held After
53,070
% of Holdings
2.8%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
5,000
Price
$16.95
Total Value
$84.75K
Shares Held After
0
% of Holdings
100.0%
Cue Biopharma, Inc. (CUE)
Ray Sumita — Chief Legal Compliance Officer
Shares
4
Price
$31.13
Total Value
$124.52
Shares Held After
118,545
% of Holdings
0.0%
Showing 1351–1400 of 3159 transactions (page 28 of 64)